NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
நேரலைசமீபத்திய அறிவிப்பு: 2026-10-12 17:37இன்று 91 பகுப்பாய்வு செய்யப்பட்டது
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
GSP Crop Science CFO Pranav Chitre Resigns, Relieving Date Set for Oct 30, 2026
GSP Crop Science announced that its Chief Financial Officer (CFO) and Key Managerial Personnel (KMP), Mr. Pranav Chitre, has resigned via a letter dated October 12, 2026. The resignation is to pursue opportunities outside the company, with his last working day designated as October 30, 2026. The company confirmed there are no other material reasons for his departure. As a business with TTM revenue of ₹1,525 crore and a market capitalization of ₹1,972 crore, appointing a capable successor will be key to financial leadership stability.
உச்சம் நம்பிக்கை
என்ன மாறியதுMr. Pranav Chitre has tendered his resignation as CFO and KMP, ending his tenure on October 30, 2026.
ஏன் இது முக்கியம்The CFO role is central to capital allocation, financial reporting, and investor relations; orderly succession is essential for continuity.
Resignation submission date: அக்டோபர் 12, 2026Relieving date: அக்டோபர் 30, 2026TTM Revenue context: Rs 1525 கோடிMarket Capitalization context: Rs 1972 கோடி
📅 குறுகிய காலம்Short-term operational impact is generally low, though the market will watch for an interim or permanent CFO announcement before October 30, 2026.
📈 நீண்ட காலம்Limited, provided the company executes a smooth handover and hires an experienced finance leader.
⚠ அபாய எச்சரிக்கைகள்
Key person transition risk until a successor CFO is announced
👀 கவனிக்க வேண்டியவை
Track announcements regarding the appointment of a new Chief Financial Officer and observe if the leadership transition causes any disruptions in financial reporting.
GSP Crop Science reported Q1 FY27 revenue of ₹386 crore, up modestly from ₹377 crore in Q1 FY26, driven by stable domestic demand offsetting temporary export supply constraints. Q1 EBITDA margin stood at ~11%, with management guiding full-year EBITDA margins between 12% and 13%. Other income of ₹8.3 crore included a one-off gain of ₹5.7 crore from the sale of ~66,000 sq. meters of leased land to a promoter group entity. Management highlighted normal Kharif demand progression in Q2, which historically accounts for a large proportion of annual profits.
உச்சம் நம்பிக்கை
என்ன மாறியதுPublication of the detailed Q1 FY27 earnings conference call transcript outlining operational performance, full-year margin targets, and one-off asset sale details.
ஏன் இது முக்கியம்Provides clarity that Q1 profit was partly aided by a non-recurring ₹5.7 crore land sale gain and sets baseline expectations for 12-13% EBITDA margins for FY27.
Q1 FY27 Revenue: ₹386 கோடிQ1 FY26 Revenue: ₹377 கோடிOne-off Land Sale Gain: ₹5.7 கோடிExpected Full-Year EBITDA Margin: 12% முதல் 13% வரைGranted Patents: >100
📅 குறுகிய காலம்Performance in the immediate weeks hinges on peak Kharif application and supply fulfillment, with raw material constraints now resolved.
📈 நீண்ட காலம்Growth depends on increasing the share of proprietary patented combination products and expanding technical manufacturing to reduce import reliance.
⚠ அபாய எச்சரிக்கைகள்
High seasonality with Q2 historically generating ~60% of annual PAT
One-off gain of ₹5.7 cr from land sale to promoter entity flattered Q1 earnings
Uneven monsoon distribution in key southern markets like AP, Telangana, and Karnataka
👀 கவனிக்க வேண்டியவை
Track Q2 FY27 performance and monsoon progression in key southern states, as Q2 typically contributes the bulk of full-year profitability.
GSP Crop Science FY26 Revenue Grows 18% to ₹1,517 Cr; PAT Up 16% to ₹94.7 Cr
GSP Crop Science reported a strong FY26 with revenue from operations reaching ₹1,517.1 crore, a 17.8% increase over the previous year. EBITDA margins improved to 12.2% from 11.7% YoY, while Profit After Tax (PAT) grew 16.3% to ₹94.7 crore. The company is aggressively utilizing ₹170 crore from its ₹400 crore IPO proceeds for debt repayment, aiming for a total reduction of ₹220 crore to strengthen the balance sheet. Strategic focus is shifting toward high-margin patented products, which now contribute 20.73% to revenue compared to just 5.07% in FY22.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has transitioned to a listed entity with a clear roadmap for debt reduction and a higher focus on patented product revenue.
ஏன் இது முக்கியம்The shift toward patented products and backward integration at the Saykha facility is designed to improve structural margins and reduce import dependency.
📅 குறுகிய காலம்The market is likely to react positively to the double-digit revenue and profit growth alongside margin improvement.
📈 நீண்ட காலம்Long-term value depends on the successful scaling of the international business (currently in 37 countries) and increasing the share of high-margin patented molecules.
⚠ அபாய எச்சரிக்கைகள்
High raw material costs (₹9,589 million in FY26)
Exposure to foreign exchange movements in international subsidiaries
Regulatory risks associated with agrochemical registrations
👀 கவனிக்க வேண்டியவை
Investors should monitor the margin expansion resulting from the new Saykha intermediate plant's backward integration and the execution of the debt reduction plan.
17% PAT Growth to ₹264 Mn in Q1FY27; Gross Margins Expand to 36.9%
GSP Crop Science reported a 17% YoY increase in PAT to ₹264 Mn for Q1FY27, despite revenue remaining relatively flat at ₹3,860 Mn (up 2%). Gross margins improved significantly by 240 bps to 36.9% due to a favorable product mix, although EBITDA margins were slightly pressured at 11.0% by higher employee and operational costs. The company achieved a milestone by acquiring the remaining 21% stake in GSP Intermediates, making it a 100% subsidiary. Growth was primarily driven by the domestic B2C and B2B segments, while international business remained muted due to raw material constraints.
உச்சம் நம்பிக்கை
என்ன மாறியதுGSP Crop Science reported its Q1FY27 financial results, finalized the full acquisition of its intermediate subsidiary, and commissioned new environmental infrastructure.
ஏன் இது முக்கியம்The expansion in gross margins despite flat revenue indicates improved pricing power or a shift toward higher-margin products; full ownership of the intermediate unit enhances backward integration.
📅 குறுகிய காலம்The stock may react positively to the margin expansion and double-digit PAT growth despite a volatile global operating environment.
📈 நீண்ட காலம்Full ownership of GSP Intermediates and infrastructure upgrades at Saykha GIDC provide a structural base for better margin control and capacity utilization over the coming years.
⚠ அபாய எச்சரிக்கைகள்
Volatility in raw material prices
Geopolitical supply chain disruptions
Muted international business performance
👀 கவனிக்க வேண்டியவை
Monitor the integration benefits of the now 100% owned GSP Intermediates and watch for a recovery in international sales as raw material supply constraints ease.
Sept 18 AGM Set; GSP Crop Science Reports Zero IPO Deviation and Appoints New Director
GSP Crop Science Limited approved its Q1 FY27 financial results on August 11, 2026, and confirmed that IPO proceeds have been utilized with zero deviation from the prospectus. The company scheduled its 41st Annual General Meeting (AGM) for September 18, 2026, with a dividend record date of September 11, 2026. Significant board changes include the appointment of Mr. Narayanan Pulukhool Nair as an Independent Director for a 5-year term, replacing Mr. Nakul Jayesh Sharedalal. Additionally, the board proposed an amendment to the Memorandum of Association (MOA) Object Clause to facilitate further business activities.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has refreshed its board composition with a new Independent Director and initiated a legal process to amend its business objects in the MOA.
ஏன் இது முக்கியம்The MOA amendment is a critical legal step that typically precedes expansion into new product lines or services, while the confirmation of IPO fund usage ensures transparency.
AGM Date: செப்டம்பர் 18, 2026Dividend Record Date: செப்டம்பர் 11, 2026Director Appointment Term: 5 yearsIPO Proceed Deviation: NilSecretarial Auditor Term: 5 years
📅 குறுகிய காலம்The stock may see activity around the September 11 record date for dividends and in response to the Q1 earnings performance.
📈 நீண்ட காலம்The 5-year board and auditor appointments suggest a focus on governance stability, while the MOA change hints at future strategic diversification.
👀 கவனிக்க வேண்டியவை
Investors should review the full Q1 financial results and the specific text of the proposed MOA amendment in the upcoming AGM notice to understand potential new business directions.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
28% PAT Growth for GSP Crop Science in Q1; IPO Proceeds Fully Utilized at ₹113 Cr
GSP Crop Science reported a strong Q1 FY27 with a 28.4% YoY increase in Net Profit to ₹31.28 crore, despite a modest 6% growth in revenue to ₹424.2 crore. The company confirmed that the ₹113.05 crore raised through its March 2026 IPO has been 100% utilized as of June 30, 2026. Significant board changes were announced, including the appointment of a new Independent Director and a 5-year term for a new secretarial auditor. The company also set September 11, 2026, as the record date for its upcoming dividend.
உச்சம் நம்பிக்கை
என்ன மாறியதுGSP Crop Science reported its first-quarter results for FY27, confirmed full utilization of IPO funds, and refreshed its board with a new Independent Director following a resignation.
ஏன் இது முக்கியம்The strong profit growth indicates improved operational efficiency post-listing. Full utilization of IPO proceeds suggests the company has completed its planned capital deployment, which should ideally lead to capacity or efficiency gains in coming quarters.
Revenue (Q1 FY27): ₹4,242.05 millionNet Profit (Q1 FY27): ₹312.82 millionIPO Proceeds Utilized: ₹1,130.53 millionQ1 வருவாய் vs TTM வருவாய்: 26.4%Dividend Record Date: செப்டம்பர் 11, 2026
📅 குறுகிய காலம்The stock may see positive sentiment due to double-digit profit growth and the confirmation of disciplined IPO fund utilization.
📈 நீண்ட காலம்The long-term trajectory depends on how the company leverages the assets/projects funded by the IPO and the impact of the proposed MOA object clause changes.
⚠ அபாய எச்சரிக்கைகள்
Resignation of an Independent Director due to other professional assignments
Agrochemical sector sensitivity to monsoon and raw material price volatility
👀 கவனிக்க வேண்டியவை
Investors should monitor the upcoming AGM on September 18, 2026, for clarity on the proposed alteration of the Memorandum of Association (MOA) and the company's growth strategy now that IPO funds are fully deployed.
GSP Crop Science Q1 PAT Rises 28% to ₹31.28 Cr; Appoints New Independent Director
GSP Crop Science reported a strong Q1 FY27 with standalone revenue growing 6% YoY to ₹424.2 crore and PAT increasing 28.4% YoY to ₹31.28 crore. The company confirmed that its IPO proceeds of ₹113.05 crore have been fully utilized as of June 30, 2026, with no deviations. Management changes include the resignation of Independent Director Nakul Sharedalal and the appointment of Narayanan Pulukhool Nair for a 5-year term. The board has also scheduled the 41st AGM for September 18, 2026, with a dividend record date of September 11, 2026.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has fully deployed its IPO capital and refreshed its board composition while delivering double-digit profit growth in the first quarter of the new fiscal year.
ஏன் இது முக்கியம்Strong earnings growth post-listing and transparent utilization of IPO funds build investor confidence in management's execution capabilities within the competitive agrochemical sector.
📅 குறுகிய காலம்The stock may see positive momentum in the coming days due to the healthy 28% profit growth and the announcement of the dividend record date.
📈 நீண்ட காலம்Sustained growth in the agrochemical space and the successful deployment of IPO funds for stated objectives suggest a stable long-term trajectory, though board stability remains important.
⚠ அபாய எச்சரிக்கைகள்
Resignation of Independent Director citing preoccupation
Proposed alteration of MOA Object Clause (details pending shareholder approval)
👀 கவனிக்க வேண்டியவை
Investors should monitor the upcoming AGM on September 18 for details on the proposed alteration to the Memorandum of Association (Object Clause) and the final dividend payout details.
₹31.28 Cr Q1 Profit: GSPCROP Reports 28% YoY Growth; Sets Sept 11 Dividend Record Date
GSP Crop Science reported a 28.4% YoY increase in standalone net profit to ₹312.82 million for Q1 FY27, despite a modest 6% revenue growth to ₹4,242.05 million. The company has fixed September 11, 2026, as the record date for its dividend, with the Annual General Meeting scheduled for September 18. Notably, the company confirmed that the ₹1,130.53 million raised through its IPO has now been fully utilized. Management also announced the appointment of a new Independent Director following the resignation of Mr. Nakul Jayesh Sharedalal.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has transitioned from its IPO phase to full capital utilization while delivering strong double-digit profit growth in Q1 FY27.
ஏன் இது முக்கியம்The 28% profit growth on 6% revenue growth suggests significant margin expansion or operational efficiency. Full utilization of IPO funds indicates the company has deployed capital into its intended growth projects.
Net Profit (Q1 FY27): ₹312.82 millionRevenue from Operations: ₹4,242.05 millionIPO Proceeds Utilized: ₹1,130.53 millionDividend Record Date: 11-செப்.-2026EPS (Basic): ₹6.72
📅 குறுகிய காலம்Positive sentiment is expected due to the earnings beat and dividend announcement; the stock may see increased activity leading up to the September 11 record date.
📈 நீண்ட காலம்The company's ability to maintain high profit growth post-IPO utilization will be critical for long-term valuation re-rating in the agrochemical sector.
⚠ அபாய எச்சரிக்கைகள்
Resignation of Independent Director Nakul Jayesh Sharedalal
Proposed alteration of MOA object clause indicates potential shift or expansion in business scope
👀 கவனிக்க வேண்டியவை
Investors should monitor the upcoming AGM on September 18 for the final dividend declaration and updates on the proposed alteration of the Memorandum of Association (MOA) object clause, which may signal new business directions.
GSP Crop Science to Consolidate ₹152.77 Cr Revenue via Merger of Two Subsidiaries
GSP Crop Science has approved a Scheme of Arrangement to merge its wholly-owned subsidiary Rajdhani Petrochemicals (RPPL) and demerge the manufacturing unit of GSP Intermediates (GIPL) into itself. RPPL contributes ₹124.51 crore in revenue (approx. 7.6% of parent revenue), while the GIPL unit adds ₹28.26 crore. As both entities are 100% subsidiaries, no new shares will be issued, ensuring zero equity dilution for shareholders. The consolidation, effective from April 1, 2026, aims to optimize borrowing costs and streamline corporate compliance.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company is consolidating its corporate structure by absorbing a wholly-owned subsidiary and a specific manufacturing division into the main listed entity.
ஏன் இது முக்கியம்This move simplifies the corporate structure, reduces the multiplicity of legal compliances, and allows for better utilization of combined resources and a stronger consolidated balance sheet.
RPPL Total Income (FY26): ₹124.51 கோடிGIPL Demerged Unit Turnover (FY26): ₹28.26 கோடிParent Total Income (FY26): ₹1,627.61 கோடிCombined Revenue vs Parent: ~9.38%Appointed Date: ஏப்ரல் 1, 2026
📅 குறுகிய காலம்The market is likely to view the consolidation positively due to the lack of equity dilution and the potential for administrative cost savings.
📈 நீண்ட காலம்Structural simplification and resource pooling should lead to improved operational efficiency and optimized borrowing costs over the next 2-3 years.
⚠ அபாய எச்சரிக்கைகள்
Regulatory approval delays from NCLT
Integration of manpower and operational processes
👀 கவனிக்க வேண்டியவை
Monitor the timeline for NCLT and regulatory approvals to confirm when operational synergies and cost savings will begin reflecting in the consolidated margins.
GSP Crop Science to merge WOS Rajdhani Petrochemicals; ₹124.5 Cr income to be consolidated
GSP Crop Science's board has approved a Scheme of Arrangement to merge its wholly-owned subsidiary Rajdhani Petrochemicals (RPPL) and demerge the manufacturing unit of GSP Intermediates (GIPL) into the parent company. RPPL brings an annual income of ₹124.51 crore (approx. 7.6% of GSP's FY26 income) and a net worth of ₹64.54 crore. As both are 100% subsidiaries, no new shares will be issued, ensuring zero dilution for existing shareholders. The restructuring, effective from the appointed date of April 1, 2026, aims to streamline operations and optimize borrowing costs within the agrochemical segment.
உச்சம் நம்பிக்கை
என்ன மாறியதுGSP Crop Science is consolidating its corporate structure by absorbing one subsidiary and a specific manufacturing unit from another subsidiary.
ஏன் இது முக்கியம்This simplifies the legal structure, reduces administrative and compliance costs, and brings the assets and liabilities of subsidiaries directly onto the parent's balance sheet for better capital utilization.
RPPL Total Income (FY26): ₹12450.90 LakhGIPL Unit Turnover: ₹2825.94 LakhGSP Net Worth (FY26): ₹73446.6 LakhRPPL Income vs GSP Income: ~7.65%Appointed Date: ஏப்ரல் 1, 2026
📅 குறுகிய காலம்Neutral; this is a procedural announcement for internal restructuring with no immediate impact on share price or capital structure.
📈 நீண்ட காலம்Modest positive due to administrative synergies, simplified regulatory compliance, and consolidated pool of finances.
⚠ அபாய எச்சரிக்கைகள்
Regulatory and NCLT approval delays
👀 கவனிக்க வேண்டியவை
Watch for the NCLT approval timeline and the subsequent integration of these units into the standalone financial reporting to assess operational synergy benefits.
GSP Crop Science Completes Acquisition of 21% Stake in GSP Intermediates; Now 100% Subsidiary
GSP Crop Science Limited has finalized the acquisition of the remaining 21% equity stake in its subsidiary, GSP Intermediates Private Limited (GIPL). The company acquired 31,50,000 equity shares of face value Rs. 10 each, completing the transaction on June 11, 2026. Consequently, GIPL has become a wholly-owned subsidiary of GSP Crop Science. This consolidation allows the company to have full control over GIPL's operations and financial performance.
முக்கிய அம்சங்கள்
Acquired 31,50,000 equity shares representing the balance 21% stake in GSP Intermediates Private Limited.GSP Intermediates Private Limited (GIPL) is now a 100% wholly-owned subsidiary of the company.The acquisition was completed on June 11, 2026, following an initial board approval/intimation on May 14, 2026.Consolidation of ownership is expected to streamline supply chain operations and financial reporting.
👀 கவனிக்க வேண்டியவை
Investors should view this consolidation as a positive move for long-term operational efficiency and full accrual of subsidiary profits. Monitor the next quarterly results for the impact of full consolidation on the bottom line.
GSP Crop Science Reports Zero Deviation in Utilization of ₹2,400 Million IPO Proceeds
GSP Crop Science Limited has officially confirmed that there is no deviation or variation in the utilization of funds raised through its recent Initial Public Offering (IPO). The company raised ₹2,400 million via a fresh issue on March 20, 2026, and has already deployed ₹965 million toward debt repayment. The Audit Committee and monitoring agency, CRISIL Ratings, have reviewed and verified that the fund usage aligns perfectly with the objects stated in the prospectus. This transparency is a positive signal for new investors regarding management's execution of the stated financial strategy.
முக்கிய அம்சங்கள்
Raised ₹2,400 million through a fresh issue and ₹1,600 million via Offer for Sale (OFS) in March 2026.Utilized ₹965 million out of the allocated ₹1,700 million for the repayment of outstanding borrowings.Spent ₹107.64 million on general corporate purposes and ₹75.05 million on IPO-related expenses.Confirmed zero deviation from the prospectus objects for the financial year ended March 31, 2026.Monitoring agency CRISIL Ratings Limited and the Audit Committee have validated the utilization report.
👀 கவனிக்க வேண்டியவை
Investors should take confidence in the company's adherence to its IPO commitments and disciplined fund deployment. Continue to monitor the utilization of the remaining ₹1,252.31 million in subsequent quarters to ensure continued alignment with growth objectives.
GSP Crop Science Pledges Additional 13.03% Stake in Subsidiary GIPL to Aditya Birla Capital
GSP Crop Science Limited has created a further pledge on 15,43,500 equity shares of its subsidiary, GSP Intermediates Private Limited (GIPL). This pledge, in favor of Aditya Birla Capital Limited, serves as security for a term loan availed by the subsidiary. With this addition, a total of 73,50,000 shares (approximately 62% of GIPL's total capital) are now encumbered. The company maintains its 79% ownership stake in GIPL, and the transaction does not result in any change of control.
முக்கிய அம்சங்கள்
Pledged 15,43,500 equity shares (13.03% of GIPL) to Aditya Birla Capital on May 26, 2026.Total shares of GIPL under pledge now stand at 73,50,000, up from 58,06,500 previously.The pledge acts as security for a term loan taken by the subsidiary company GIPL.GSP Crop Science continues to hold a 79% majority stake (1,18,50,000 shares) in GIPL.No change in management control or ownership structure of the subsidiary company.
👀 கவனிக்க வேண்டியவை
Investors should monitor the financial health and debt-servicing capability of the subsidiary GIPL, as a significant portion of its shares are now pledged. While ownership remains intact, high encumbrance levels are a key risk factor to track in future quarterly reports.
GSP Crop Science FY26 Net Profit rises 19% to ₹898M; ₹1 Dividend declared
GSP Crop Science reported a strong performance for the financial year ended March 31, 2026, with revenue from operations growing 14% YoY to ₹16,059.06 million. Net profit increased by 18.8% to ₹898.35 million compared to ₹755.90 million in the previous year. The company also announced a final dividend of ₹1.00 per share and a transition in the CFO role, with Pranav Chitre taking over from June 1, 2026.
முக்கிய அம்சங்கள்
Annual Revenue from Operations increased 14% YoY to ₹16,059.06 million in FY26.Net Profit for the full year rose to ₹898.35 million from ₹755.90 million in FY25.Recommended a final dividend of ₹1.00 per equity share (10% of face value).Appointed Mr. Pranav Chitre as Chief Financial Officer effective June 1, 2026.Cash and Cash Equivalents significantly improved to ₹1,538.25 million from ₹88.94 million YoY.
👀 கவனிக்க வேண்டியவை
Investors should take note of the healthy double-digit growth in both revenue and profit; the stock remains a 'Watch' to see how the new CFO and the re-designated Strategy Director drive future growth.
GSP Crop Science FY26 Revenue Rises 14% to ₹16,059M; Declares ₹1 Dividend & Appoints New CFO
GSP Crop Science reported a steady performance for FY26, with revenue from operations growing 14% YoY to ₹16,059.06 million. Net profit for the year increased to ₹898.35 million from ₹755.90 million in the previous fiscal, representing an 18.8% growth. The board has recommended a final dividend of ₹1.00 per equity share (10% of face value). Additionally, the company announced a management transition with Mr. Pranav Chitre taking over as CFO from June 1, 2026, while the current CFO moves to a strategy-focused executive role.
முக்கிய அம்சங்கள்
Revenue from operations grew 14% YoY to ₹16,059.06 million in FY26 compared to ₹14,086.94 million in FY25.Net profit for the full year increased by 18.8% to ₹898.35 million from ₹755.90 million.Recommended a final dividend of ₹1.00 per share on a face value of ₹10 for FY26.Appointed Mr. Pranav Chitre as the new Chief Financial Officer effective June 1, 2026.Basic and Diluted Earnings Per Share (EPS) improved to ₹22.88 from ₹19.37 in the previous year.
👀 கவனிக்க வேண்டியவை
Investors should take note of the consistent double-digit growth in both revenue and profitability. The planned management transition and dividend payout reflect corporate stability and a positive outlook for the upcoming fiscal year.
GSP Crop Science FY26 Net Profit Up 17.7% to ₹898.35M; ₹1 Dividend Declared
GSP Crop Science reported a solid financial performance for the fiscal year ended March 31, 2026, with revenue from operations rising 14% to ₹16,059.06 million. The company's net profit saw a healthy increase of 17.7%, reaching ₹898.35 million compared to ₹763.07 million in the previous year. A final dividend of ₹1.00 per share has been recommended, reflecting a 10% payout on face value. The company also announced a management shuffle, appointing Pranav Chitre as the new CFO while the outgoing CFO moves into a strategic leadership role.
முக்கிய அம்சங்கள்
FY26 Revenue from Operations increased 14% YoY to ₹16,059.06 millionFull-year Net Profit grew 17.7% to ₹898.35 million from ₹763.07 million in FY25Board recommended a final dividend of ₹1.00 per equity share (10% of face value)Cash and cash equivalents surged to ₹1,538.25 million from ₹88.94 million YoYManagement transition: Pranav Chitre appointed as CFO; Shail Jayesh Shah moved to ED - Strategy
👀 கவனிக்க வேண்டியவை
The company demonstrates consistent growth in both top and bottom lines along with a significantly strengthened cash position. Investors should maintain their positions as the company transitions into a new strategic growth phase under revamped leadership.
GSP Crop Science FY26 Net Profit Rises 18% to ₹898M; Recommends ₹1 Dividend
GSP Crop Science reported a strong financial performance for FY26, with standalone revenue from operations increasing 14% YoY to ₹16,059.06 million. Net profit for the year grew by 17.7% to ₹898.35 million, up from ₹763.07 million in FY25. The board has recommended a final dividend of ₹1.00 per share (10% of face value). Additionally, the company announced a management transition with Pranav Chitre appointed as the new CFO effective June 1, 2026, as the current CFO moves into a strategy-focused role.
முக்கிய அம்சங்கள்
Standalone Revenue from Operations grew 14% YoY to ₹16,059.06 million in FY26.Net Profit for the year increased to ₹898.35 million from ₹763.07 million in the previous fiscal.Recommended a final dividend of ₹1.00 per equity share for FY26.Cash and cash equivalents surged to ₹1,538.25 million, supported by a ₹2,400 million fresh issue of shares during the year.Appointed Pranav Chitre as CFO effective June 1, 2026, succeeding Shail Jayesh Shah.
👀 கவனிக்க வேண்டியவை
The company shows healthy growth in both top-line and bottom-line figures along with a significantly strengthened balance sheet. Investors should monitor how the company utilizes its substantial cash reserves for future growth initiatives under the new leadership.
GSP Crop Science to Acquire Remaining 21% Stake in GIPL for Rs 3.15 Crore
GSP Crop Science Limited has approved the acquisition of the remaining 21% equity stake in its subsidiary, GSP Intermediates Private Limited (GIPL), for a cash consideration of Rs 3.15 crore. The company will acquire 31,50,000 equity shares at a par value of Rs 10 per share, making GIPL a wholly-owned subsidiary. This strategic move aims to provide GSP Crop Science with complete financial and operational control over its intermediate manufacturing. GIPL recently commenced commercial production, reporting a turnover of Rs 122.01 lakh for FY 2024-25.
முக்கிய அம்சங்கள்
Acquisition of 31,50,000 equity shares representing the balance 21% stake in GIPLTotal cash consideration of Rs 3.15 crore at a par value of Rs 10 per shareGIPL to become a wholly-owned subsidiary upon completion within approximately 4 monthsGIPL reported FY 2024-25 turnover of Rs 122.01 lakh following recent commencement of productionStrategic objective to enable seamless operational integration and long-term manufacturing scalability
👀 கவனிக்க வேண்டியவை
Investors should monitor the scaling of GIPL's production capacity as it becomes a wholly-owned entity, which could improve margins through better supply chain integration. The consolidation of ownership is a positive step for long-term governance and strategic flexibility.
GSP Crop Science Credit Rating Upgraded to ICRA A+ (Stable) for Rs 516.16 Cr Facilities
ICRA Limited has upgraded the credit ratings for GSP Crop Science Limited across its Rs. 516.16 Crore bank facilities. The long-term rating moved from [ICRA]A to [ICRA]A+ with a Stable outlook, while the short-term rating improved from [ICRA]A2+ to [ICRA]A1. This upgrade signifies a strengthened financial profile and improved debt-servicing capability. Such revisions often allow companies to negotiate better interest rates with lenders, potentially improving net margins.
முக்கிய அம்சங்கள்
Long-term rating upgraded to [ICRA]A+ (Stable) from [ICRA]A (Stable) for Rs. 516.16 Crore facilities.Short-term rating upgraded to [ICRA]A1 from [ICRA]A2+ across various non-fund based limits.The rating covers Rs. 55.18 Crore in term loans and Rs. 267.50 Crore in fund-based/non-fund based limits.Upgrades were assigned by ICRA Limited following a review of the company's financial instruments and bank facilities.
👀 கவனிக்க வேண்டியவை
The credit upgrade is a positive signal for shareholders, indicating reduced financial risk and potential for lower borrowing costs. Investors should maintain a positive outlook on the stock's stability and monitor for margin improvements in future earnings.
GSP Crop Science Q3 FY26: PAT Rises to ₹75 Cr, EBITDA Up 32% YoY
GSP Crop Science reported a strong performance for the nine months ended December 31, 2025, with revenue reaching ₹1,114 crores. The company's EBITDA grew by 32% year-on-year to ₹153 crores, while PAT stood at ₹75 crores despite a ₹4.5 crore exceptional provision for labor codes. Management highlighted a significant shift in product mix, with patented products now contributing 17% of revenue compared to just 3% three years ago. To counter rising raw material and logistics costs, the company has implemented a 10-15% price hike effective April 2026.
முக்கிய அம்சங்கள்
9-month revenue reached ₹1,114 crores with an EBITDA of ₹153 crores, marking a 32% YoY growth.Net profit (PAT) increased to ₹75 crores from ₹59.6 crores in the previous year, despite a ₹4.5 crore labor code provision.Patented product contribution to total revenue surged from 3% to 17% over the last three years.Implemented a 10-15% price increase from April 1, 2026, to offset rising crude and logistics costs.Strong R&D pipeline with 102 patents received and 108 more in the pipeline to drive future growth.
👀 கவனிக்க வேண்டியவை
Investors should monitor the company's ability to maintain margins following the 10-15% price hike and the continued ramp-up of patented product sales. The focus on backward integration to reduce China dependency is a positive long-term structural driver.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
